The oculomotor periphery: The clinician's focus is no longer a basic science stepchild

Current Opinion in Neurobiology

Volumn 7, Issue 6, 1997, Pages 880-887

  Porter, John D ^a   Karathanasis, Paraskevi ^a   Bonner, Philip H ^b   Brueckner, Jennifer K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRAOCULAR MUSCLE; HUMAN; MEDICAL RESEARCH; MOLECULAR BIOLOGY; MOTONEURON; NEUROMUSCULAR SYNAPSE; OCULOMOTOR SYSTEM; ORBIT; PRIORITY JOURNAL; REVIEW;

EID: 0031463592     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(97)80150-X     Document Type: Article

References (81)

1. Brueckner JK, Itkis O, Porter JD: Spatial and temporal patterns of myosin heavy chain expression in developing rat extraocular muscle. J Musc Res Cell Motil 1996, 17:297-312. Documentation of the myosin heavy chain expression patterns in maturing extraocular muscle (EOM). These data establish a unique regulatory pattern for embryonic myosin, with both delayed isoform switching and retention of expression into adulthood. In addition, the expression of myosin isoforms traditionally linked to fatigue-resistant fiber types IIA and IIX are surprisingly sparse in EOM and appear late in the maturational sequence. The postnatal onset and limited expression pattern of a myosin that is uniquely observed in EOM (see [7]) is shown to correlate with visuomotor maturation.
2. Jacoby J, Ko K, Weiss C, Rushbrook JI: Systemic variation in myosin expression along extraocular muscle fibres of the adult rat J Musc Res Cell Motil 1989, 11:25-40.
3. Briggs MH, Jacoby J, Davidowitz J, Schachat FH: Expression of a novel combination of fast and slow troponin T isoforms in rabbit extraocular muscles. J Muse Res Cell Motil 1988, 9:241-247.
4. Rushbrook JI, Weiss C, Ko K, Feurman MH, Carleton S, Ing A, Jacoby J: Identification of alpha-cardiac myosin heavy chain mRNA and protein in extraocular muscle of the adult rabbit J Muse Res Cell Motil 1994, 15:505-515.
5. McLoon LK, Wirtschafter JD: N-CAM is expressed in mature extraocular muscles in a pattern conserved among three species. Invest Ophthalmol Vis Sci 1996; 37:318-327. Demonstrates that some extraocular muscle (EOM) fibers, particularly those in the orbital layer, do not downregulate an embryonic isoform of neural cell adhesion molecule. These data, together with the continued expression of embryonic myosin [1••,2] and the presence of an EOM-specific myosin [1••,7] in this same muscle layer, establish the particularly unique nature of orbital-layer fiber types.
6. Kaminski HJ, Kusner LL, Block CH: Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci 1996, 37:345-351. The authors examined the expression of γ (fetal) and ε (adult) acetylcholine receptor (AChR) subunit protein at neuromuscular junctions of adult rat extraocular muscle (EOM), diaphragm, and limb muscle. They observed restriction of subunit expression to EOM, at endplates of both singly and multiply innervated fiber types: the γ subunit colocalized with E subunit at some, but not all, neuromuscular junctions. They argue that the coexpression of AChRs composed of fetal and adult isoforms at the same neuromuscular junctions might affect the contractile properties and disease susceptibility of EOM.
7. Wieczorek DF, Periasamy M, Butler-Browne GS, Whalen RG, Nadal-Ginard B: Co-expression of multiple myosin heavy chain genes, in addition to a tissue-specific one, in extraocular muscle. J Cell Biol 1985, 101:618-629.
8. Schmidt ED, Schmidt EDL, van der Gaag R, Ganpat R, Broersma L, de Boer PAJ, Moorman AFM, Lamers WH, Wiersinga WM, Koornneef L: Distribution of the nuclear thyroid-hormone receptor in extraocular and skeletal muscles. J Endocrinol 1992, 133:67-74.
9. Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlie JP: Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR yto-e switch. Dev Biol 1996, 179:223-238. Utilized immunocytochemical techniques and transgenic mice with a reporter construct linked to promoter elements of acetylcholine receptor (AChR) subunits to examine the spatial and temporal switching of embryonic to adult AChR isoforms. Confirmed finding of Kaminski et al. [6•] that extraocular muscle (EOM) retains embryonic AChR subunit expression.
10. Major BJ, Cures A, Frauman AG: The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves' ophthalmopathy. Biochem Biophys Res Commun 1997, 230:493-496. Molecular analysis of thyrotropin receptor distribution. Show that the recep-tor that is the autoimmune target for Graves' disease is expressed, among skeletal muscles, only in extraocular muscle (EOM). While a prior study [8] was suggestive, this finding establishes a definitive basis for the targeting of EOM in Graves' ophthalmopathy.
11. Scott AB, Collins CC: Division of labor in human extraocular muscle. Arch Ophthalmol 1973, 90:319-322.
12. Porter JD, Baker RS, Ragusa RJ, Brueckner JK: Extraocular muscles: basic and clinical aspects of structure and function. Surv Ophthalmol 1995, 39:451-484.
13. Porter JD, Baker RS: Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology 1996, 46:30-37. Review article that briefly summarizes basic differences between extraocular muscle (EOM) and other skeletal muscles. Phenotypic differences in muscle types are related to their differential susceptibility to disease. Together with [12,14], this paper provides a comprehensive description of EOM in health and disease.
14. Spencer RF, Porter JD: Structural organization of the extraocular muscles. In Reviews in Oculomotor Research, vol 2. Neuroanatomy of the Oculomotor System. Edited by Büttner-Ennever JA. New York: Elsevier Science Publishers; 1988:33-79.
15. Robinson DA: Oculomotor unit behavior in the monkey. J Neurophysiol 1970, 33:393-404.
16. Kaminski HJ, Ruff RL: Ocular muscle involvement by myasthenia gravis. Ann Neurol 1997, 41:419-420. This editorial succinctly reconciles conflicting evidence [6•,9•,18•] of a role for acetylcholine receptor (AChR) isoform expression differences in the targeting of the extraocular muscle (EOM) and sparing of other skeletal muscles in some cases of myasthenia gravis (MG). It is clear that the mechanism(s) linking EOM and MG are more complex than was thought in earlier work.
17. 7. Kaminski HJ, Kusner LL, Nash KV, Ruff RL: The γ-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris. Neurology 1995, 45:516-518.
18. MacLennan C, Beeson D, Buijs A-M, Vincent A, Newsom-Davis J: Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 1997, 41:423-431. Examined expression of fetal acetylcholine receptor (AChR) subunit in extraocular muscle (EOM) and other muscles in human. RNase protection assays showed that subunit expression in EOM was comparable to other skeletal muscles and that subunit expression was higher in EOM than in other muscles. The authors argue that their results do not support the notion linking AChR isoform expression patterns to the targeting of myasthenia gravis to EOM.
19. Partridge T: Pathophysiology of muscular dystrophy. Br J Hosp Med 1993, 49:26-36.
20. Campbell KP: Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995, 80:675-679.
21. Hopf WF, Turner PR, Denetclaw WF, Reedy R, Steinhardt RA: A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am J Physiol Cell Physiol 1996, 271:1325-1339.
22. Jackson MJ, Edwards RHT: Development of changes in cation content of muscles from the 129 ReJ dystrophic mouse. Comp Biochem Physiol 1987, 87:349-354.
23. Reeve JL, McArdle A, Jackson MJ: Age-related changes in muscle calcium content in dystrophin-deficient mdx mice. Muscle Nerve 1997, 20:357-360. The authors add to the controversy of which pathogenic event comes first in muscular dystrophy, calcium-mediated or free-radical-mediated cell death. They argue that the elevation in intracellular free calcium occurs too late to be a proximal cause of cell death, but instead is a consequence. Although these data are from limb muscle, which degenerates in muscular dystrophy, it is important to understand the primary pathogenic mechanisms so one can figure out how the extraocular muscle (EOM) is protected in this disease [28-30].
24. Austin LM, DeNiese M, McGregor A, Arthur W, Guru Sihghe A, Gould MK: Potential oxyradical damage and energy states in individual muscle fibers from degenerating muscle diseases. Neuromusc Disord 1992, 2:27-33.
25. Ragusa RJ, Chow CK, St Clair DK, Porter JD: Extraocular, limb and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice. J Neurol Sci 1996, 139:180-166. Comparative biochemical evaluation of antioxidant enzyme activity patterns in extraocular muscle (EOM) versus two other commonly studied skeletal muscles. Study establishes the high antioxidant capacity of EOMs, relative to other skeletal muscle.
26. Ragusa RJ, Chow CK, Porter JD: Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromusc Disord 1997, 7:379-386. Provides, with [25•], an evaluation of the hypothesis that the high antioxidant capacity of extraocular muscle (EOM) might play a role in protection of this muscle group in muscular dystrophy. Also demonstrates that EOM is normally under significant oxidative stress, probably because of high activity levels and mitochondrial respiratory activity.
27. Rando TA, Dziesietnik M-H, Dhawan J, Yu Y, Whirl M: Oxidative injury precedes muscle necrosis in dystrophin-deficient (mdx) mice. Neurology 1997, 48:A442-A443.
28. Kaminski HJ, Al-Hakim M, Leigh RJ, Katiriji MB, Ruff RL: Extraocular muscles are spared in advanced Duchenne dystrophy. Ann Neurol 1992, 32:586-588.
29. Karapati G, Carpenter S, Prescott S: Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 1988, 11:795-803.
30. Khurana TS, Prendergast RA, Alameddine H, Tome FMS, Fardeau M, Arahata K, Sugita H, Kunkel LM: Absence of extraocular muscle pathology in Duchenne muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 1995, 182:467-475.
31. Bakker AJ, Head SI, Williams DA, Stephenson DG: Calcium levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. J Physiol 1993, 460:1-13.
32. Turner RR, Fong P, Denetclaw WF, Steinhardt RA: Increased calcium influx in dystrophic muscle. J Cell Biol 1991, 115:1701-1712.
33. Fong P, Turner PR, Denetclaw WF, Steinhardt RA: Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 1990, 250:673-676.
34. Celio MR, Heizmann CW: Calcium-binding protein parvalbumin is associate with fast contracting muscle fibres. Nature 1982, 297:504-506.
35. Schoffner JM, Wallace DC: Oxidative phosphorylation diseases: disorders of two genomes. Adv Hum Genet 1990, 19:267-330.
36. Schoffner JM, Wallace DC: Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment Ann Rev Nutr 1994, 14:535-568.
37. Borchert MS: Diseases of the ocular muscles. In Principals and Practice of Ophthalmology, vol 4. Edited by Albert DM, Jakobiec FA. Philadelphia: WB Sanders; 1994:2490-2498.
38. Fassati A, Bordoni A, Amboni P, Fortunato F, Fagiolari G, Bresolin N, Prelle A, Comi G, Scarlato G: Chronic progressive external ophthalmoplegia: a correlative study of quantitative molecular data and histochemical and biochemical profile. J Neurol Sci 1994, 123:140-146.
39. Ringel SP, Wilson WB, Barden MT: Extraocular muscle biopsy in chronic progressive external ophthalmoplegia. Ann Neurol 1978, 6:326-339.
40. Suomalainen A, Majander A, Wallin M, Setälä K, Kontula K, Leinonen H, Salmi T, Paetau A, Haltia M, Valanne L et al.: Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology 1997, 48:1244-1253.
41. Takeda S, Ohama E, Ikuta F: Involvement of extraocular muscle in mitochondrial encephalomyopathy. Acta Neuropathol 1990, 80:118-122.
42. Chang TS, Johns DR, Walker D: Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes. Arch Ophthalmol 1994, 111:1254-1262.
43. Shigenaga MK, Hagen TM, Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994, 91:10771-10778.
44. Münscher C, Müller-Höcker J, Kadenbach B: Human aging is associated with various point mutations in tRNA genes of mitochondrial DNA. Biol Chem Hoppe Seyler 1993, 374:1099-1104.
45. Münscher C, Rieger T, Müller-Höcker J, Kadenbach B: The point mutation of mitochondrial DNA characteristic for MERRF disease is found also in healthy people of different ages. FEBS Lett 1993, 317:27-30.
46. Müller-Höcker J, Seibel P, Schneiderbanger K, Kadenbach B: Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibres in the elderly. Virchows Arch [A] 1993, 422:7-15.
47. Müller-Höcker J, Schafer S, Link TA, Possekel S, Hammer C: Defects of the respiratory chain in various tissues of old monkeys: a cytochemical-immunochemical study. Mech Ageing Dev 1996, 86:197-213. Previous studies have established an oxidative stress-based mitochondrial model of aging [43]. The authors extend this model to normal aging muscle. This paper, and others by this group [44-46], establish that this type of aging may be accelerated in extraocular muscle (EOM), thereby potentially explaining the propensity for mitochondrial myopathies in EOM.
48. Porter JD, Hauser KF: Diversity and developmental regulation of extraocular muscle: progress and prospects. Acta Anat 1993, 147:197-206.
49. Porter JD, Hauser KF: Survival of extraocular muscle in long-term organotypic culture: differential influence of appropriate and inappropriate motoneurons. Dev Biol 1993, 160:39-50.
50. Couly GF, Coltey PM, Le Douarin NM: The developmental fate of the cephalic mesoderm in quail-chick chimeras. Development 1992, 114:1-15.
51. Wachtler F, Jacob JJ, Jacob M, Christ B: The extrinsic ocular muscles in birds are derived from the prechordal plate. Naturwissenschaften 1984, 71:379-380.
52. Wahl CM, Noden DM, Baker R: Developmental relations between sixth nerve motor neurons and their targets in the chick embryo. Dev Dynam 1994, 201:191-202.
53. Porter JD, Baker RS: Prenatal morphogenesis of primate extraocular muscle: neuromuscular junction formation and fiber type differentiation. Invest Ophthalmol Vis Sci 1992, 33:657-670.
54. Kiorpes L, Boothe RG: Naturally occurring strabismus in monkeys (Macaca nemestrina). Invest Ophthalmol Vis Sci 1981, 20:257-263.
55. Porter JD, Baker RS: Developmental adaptations in the extraocular muscles of Macaca nemestrina may reflect a predisposition to strabismus. Strabismus 1993, 1:173-180.
56. Robinson DA: The functional behavior of the peripheral ocular motor apparatus: a review. In Disorders of Ocular Motility. Edited by Kommerell G. Munich: Bergman; 1978:43-61.
57. Spencer RF, McNeer KW: Botulinum toxin paralysis of adult monkey extraocular muscle: structural alterations in orbital, singly innervated muscle fibers. Arch Ophthalmol 1987, 105:1703-1711.
58. Spencer RF, McNeer KW: Morphology of the extraocular muscles in relation to the clinical manifestation of strabismus. In Strabismus and Amblyopia. Edited by Lennerstrand G, von Noorden GK, Campos EC. New York: Plenum Press; 1988:37-46.
59. McNeer KW, Tucker MG, Spencer RF: Characterization and classification of esotropia and its management with botulinum toxin. Ophthalmol Clin N Am 1997, 10:435-449. The authors carefully evaluate the types of and treatments for esotropia. They relate the notion that esotropia is heterogeneous and that effective treatments for strabismus are possible only with a thorough characterization of the type and properties of esotropia. This group has been very successful in discerning the subtleties of disease type and state for proper use of botulinum toxin treatments.
60. Sparks DL, Mays LE, Gurski MR, Hickey TL: Long- and short-term monocular deprivation in the rhesus monkey: effects on visual fields and optokinetic nystagmus. J Neurosci 1986, 6:1771-1780.
61. Rothblat LA, Schwartz ML, Kasdan PM: Monocular deprivation in the rat: evidence for an age-related defect in visual behavior. Brain Res 1978, 158:456-460.
62. Kerns JM, Rothblat LA: The effects of monocular deprivation on the development of the rat trochlear nerve. Brain Res 1981, 230:367-371.
63. Shiraki K, Miyazaki S, Shimo-Oku M: Influence of visual deprivation on the visual and oculomotor system: acetylcholinesterase activity in oculomotor neurons. Exp Neurol 1988, 99:342-352.
64. Lennerstrand G, Hanson J: Contractile properties of extraocular muscle in cats reared with monocular lid closure and artificial squint Acta Ophthalmol 1979, 57:591-599.
65. Brueckner JK, Porter JD: Modulation of extraocular muscle maturation by the developing visuomotor system. J Musc Res Cell Motil 1997, 18:203. This preliminary report examines the role played by the developing visual system in modulation of extraocular muscle (EOM) myosin expression patterns. Strategies were used to alter visual development and the consequences for EOM myosin then evaluated. Alterations in the expression of a myosin unique to the EOMs [7] were of particular interest, as this isoform appears during the postnatal maturation of visuomotor systems [1••]. Both dark rearing and monocular deprivation directly altered eye muscle properties by changing the expression patterns of some of the many myosin isoforms found in EOMs. Notably, mRNA levels for the myosin isoform that is specific for EOMs were reduced dramatically in the fiber types normally expressing this isoform. By contrast, the cellular distribution and levels of the EOM-specific myosin mRNA was not altered in monocularly deprived EOMs. Together, these data suggest that at least some of the unique properties of EOMs might result from the unusual demands that are placed upon these muscles.
66. Engle EC, Kunkel LM, Specht LA, Beggs AH: Mapping a gene for congenital fibrosis of the extraocular muscles to the centromeric region of chromosome 12. Nat Genet 1994, 7:69-73.
67. Engle EC, Marondel I, Hcutman WA, de Vries B, Loewenstein A, Lazar M, Ward DC, Kucherlapati R, Beggs AH: Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): genetic homogeneity, linkage refinement, and physical mapping on chromosome 12. Am J Hum Genet 1995, 57:1086-1094.
68. Engle EC, Castro AE, Macy ME, Knoll JHM, Beggs AH: A gene for isolated congenital ptosis maps to a 3-cM region within 1p32-p34.1. Am J Hum Genet 1997, 60:1150-1157.
69. Engle EC, Gumernov B, McKeown CA, Schatz M, Johns DR, Porter JD, Beggs AH: Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol 1997, 41:314-325. Extends the genetic characterization of congenital fibrosis of the extraocular muscles (CFEOM) by this group [66,67], initiating the development of a model for this disease. Reports correlated genetic and morphopathologic analysis of a defined group of patients with CFEOM. These patients exhibit ptosis, external ophthalmoplegia, and downward deviation of the eyes. Absence of the levator palpebrae superioris and reduction of the superior rectus muscle correlate with the loss or reduction in the motoneuron pools innervating these muscle groups. The authors suggest that a disease long thought to result from muscle fibrosis actually may have a neurologic origin. The correlative approach used by the authors is effective in discerning disease mechanisms and should be applied to a broader range of ocular motility disorders.
70. Miller NR, Kiel SM, Green WR, Clark AW: Unilateral Duane's retraction syndrome (type 1). Arch Ophthalmol 1982, 100:1468-1472.
71. Fritzsch B, Nichols DH, Echelard Y, McMahon AP: Development of midbrain and anterior hindbrain ocular motoneurons in normal and wnt-1 knockout mice. J Neurobiol 1995, 27:457-469.
72. Porter JD, Baker RS: Absence of oculomotor and trochlear motoneurons leads to altered extraocular muscle development in the Wnt-1 null mutant mouse. Dev Brain Res 1997, 100:121-126.
73. Miller JM: Functional anatomy of normal human rectus muscles. Vision Res 1989, 29:223-240.
74. Shin GS, Demer JL, Rosenbaum AL: High resolution, dynamic, magnetic resonance imaging in complicated strabismus. J Pediatr Ophthalmol Strabismus 1996, 33:282-290. Documents the significant potential of high resolution magnetic resonance imaging (MRI) in diagnosis of and treatment planning for difficult strabismus cases. Results illustrate importance of understanding anatomy of extraocular muscles (EOMs) and their orbital connective tissues in the clinical manage-ment of ocular motility disorders.
75. Demer JL, Miller JM, Poukens V: Surgical implications of the rectus extraocular muscle pulleys. J Pediatr Ophthalmol Strabismus 1996, 33:208-218.
76. Demer JL, Miller JM, Poukens V, Vinters HV, Glasgow BJ: Evidence for fibromuscular pulleys of the recti extraocular muscles. Invest Ophthalmol Vis Sci 1995, 36:1125-1136.
77. Porter JD, Poukens V, Baker RS, Demer JL: Structure-function correlations in the human medial rectus extraocular muscle pulleys. Invest Ophthalmol Vis Sci 1996, 37:468-472. Provides a morphologic description of the extraocular muscle (EOM) pulleys at the electron microscopic level. These data document the substantive nature of the pulleys.
78. Clark RA, Miller JM, Demer JL: Location and stability of rectus muscle pulleys: muscle paths as a function of gaze. Invest Ophthalmol Vis Sci 1997, 38:227-240. A landmark paper in relating orbital anatomy to ocular motility disorders. The authors establish that the connective tissue pulleys previously described by this group [76,77•] may undergo positional changes that represent a potential cause of some types of strabismus. Strabismus surgery outcomes sometimes are inconsistent. The hard science approach used by these authors should significantly advance the efficacy of treatments for strabismus.
79. Robinson DA: A quantitative analysis of extraocular muscle cooperation and squint Invest Ophthalmol 1975, 14:801-825.
80. Miller JM, Shamaeva I: Orbit 1.5 Gaze Mechanics Simulation. San Francisco: Eidactics; 1995.
81. Guyton DL, Weingarten PE: Sensory torsion as the cause of primary oblique muscle overaction/underaction and A- and V-pattern strabismus. Binoc Vis Eye Musc Surg Quart 199,; 9:209-236.